2 results
Approved WMOCompleted
To evaluate the efficacy of 9mg budesonide/day and 3g mesalazine/day compared to placebo for the induction of remission in lymphocitic colitis.
Approved WMOWill not start
To collect long term data on safety and tolerability of dovitinib monotherapy.